MITSUYA; Hiroaki
Patent Applications and Registrations
Patent applications and USPTO patent grants for MITSUYA; Hiroaki.The latest application filed is for "method for assisting determination of exacerbation risk of covid-19".
Company Profile
5.39.27
- MITSUYA; Hiroaki - Tokyo JP
- Mitsuya; Hiroaki - Kumamoto JP
- Mitsuya; Hiroaki - Chevy Chase MD
- Mitsuya; Hiroaki - Kumamoto-shi JP
- Mitsuya; Hiroaki - Rockville MD
Patent Activity
| Patent | Date |
|---|---|
| Method For Assisting Determination Of Exacerbation Risk Of Covid-19 App 20220268786 - MITSUYA; Hiroaki ; et al. | 2022-08-25 |
| Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS Grant 11,390,630 - Ghosh , et al. July 19, 2 | 2022-07-19 |
| Macrocyclic HIV-1 protease inhibitors and uses thereof Grant 11,230,550 - Ghosh , et al. January 25, 2 | 2022-01-25 |
| Tricyclic P2-ligand Containing Potent Hiv-protease Inhibitors Against Hiv/aids App 20210261563 - Ghosh; Arun K. ; et al. | 2021-08-26 |
| Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS Grant 11,028,096 - Ghosh , et al. June 8, 2 | 2021-06-08 |
| Nucleoside derivative having physiological activity such as antiviral activity Grant 10,933,067 - Mitsuya , et al. March 2, 2 | 2021-03-02 |
| Macrocyclic Hiv-1 Protease Inhibitors And Uses Thereof App 20200165264 - Ghosh; Arun K. ; et al. | 2020-05-28 |
| Tricyclic P2-ligand Containing Potent Hiv-protease Inhibitors Against Hiv/aids App 20190359626 - Ghosh; Arun K. ; et al. | 2019-11-28 |
| HIV-1 protease inhibitors and uses thereof Grant 10,472,372 - Ghosh , et al. Nov | 2019-11-12 |
| Nucleoside Derivative Having Physiological Activity Such As Antiviral Activity App 20190275050 - MITSUYA; Hiroaki ; et al. | 2019-09-12 |
| Hiv-1 Protease Inhibitors And Uses Thereof App 20180244688 - Ghosh; Arun K. ; et al. | 2018-08-30 |
| Fitness assay and associated methods Grant 9,889,115 - Erickson , et al. February 13, 2 | 2018-02-13 |
| HIV-1 protease inhibitors and uses thereof Grant 9,670,225 - Ghosh , et al. June 6, 2 | 2017-06-06 |
| Hiv-1 Protease Inhibitors And Uses Thereof App 20170088555 - Ghosh; Arun K. ; et al. | 2017-03-30 |
| Compounds and methods for treating HIV Grant 9,499,558 - Ghosh , et al. November 22, 2 | 2016-11-22 |
| Fused tricyclic ether carbamates and their use Grant 9,487,541 - Ghosh , et al. November 8, 2 | 2016-11-08 |
| HIV-1 protease inhibitors having gem-di-fluoro bicyclic P2-ligands Grant 9,346,820 - Ghosh , et al. May 24, 2 | 2016-05-24 |
| C-3 substituted bicyclooctane based HIV protease inhibitors Grant 9,309,213 - Ghosh , et al. April 12, 2 | 2016-04-12 |
| Compounds And Methods For Treating Hiv App 20150225414 - Ghosh; Arun K. ; et al. | 2015-08-13 |
| CCR5 antagonists for treating HIV Grant 9,062,057 - Ghosh , et al. June 23, 2 | 2015-06-23 |
| Compunds and methods for treating HIV Grant 9,024,038 - Ghosh , et al. May 5, 2 | 2015-05-05 |
| Hiv-1 Protease Inhibitors Having Gem-di-fluoro Bicyclic P2-ligands App 20150072958 - Ghosh; Arun K. ; et al. | 2015-03-12 |
| Ccr5 Antagonists For Treating Hiv App 20140221420 - Ghosh; Arun K. ; et al. | 2014-08-07 |
| Fused Tricyclic Ether Carbamates And Their Use App 20140179754 - GHOSH; Arun K. ; et al. | 2014-06-26 |
| C-3 Substituted Bicyclooctane Based Hiv Protease Inhibitors App 20140148508 - Ghosh; Arun K. ; et al. | 2014-05-29 |
| Fitness Assay And Associated Methods App 20140011815 - Erickson; John W. ; et al. | 2014-01-09 |
| Method of treating HIV infection Grant 8,597,876 - Erickson , et al. December 3, 2 | 2013-12-03 |
| Compounds And Methods For Treating Hiv App 20130289067 - GHOSH; Arun K. ; et al. | 2013-10-31 |
| Fused tricyclic ether carbamates and their use Grant 8,563,597 - Ghosh , et al. October 22, 2 | 2013-10-22 |
| Fused Tricyclic Ether Carbamates And Their Use App 20130158094 - Ghosh; Arun K. ; et al. | 2013-06-20 |
| 4' -C-substituted-2-haloadenosine derivative Grant 8,039,614 - Kohgo , et al. October 18, 2 | 2011-10-18 |
| Methods And Compositions For Treating Hiv Infections App 20100113582 - Ghosh; Arun K. ; et al. | 2010-05-06 |
| 4'-c-substituted-2-haloadenosine derivative Grant 7,625,877 - Kohgo , et al. December 1, 2 | 2009-12-01 |
| 4' -C-substituted-2-haloadenosine derivative App 20090234110 - Kohgo; Satoru ; et al. | 2009-09-17 |
| Fitness assay and associated methods Grant 7,470,506 - Erickson , et al. December 30, 2 | 2008-12-30 |
| 4' -C-substituted-2-haloadenosine derivative App 20080153774 - Kohgo; Satoru ; et al. | 2008-06-26 |
| Fitness Assay And Associated Methods App 20080085918 - ERICKSON; John W. ; et al. | 2008-04-10 |
| 4'-C-substituted-2-haloadenosine derivative Grant 7,339,053 - Kohgo , et al. March 4, 2 | 2008-03-04 |
| Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient Grant 7,285,552 - Mitsuya , et al. October 23, 2 | 2007-10-23 |
| 4' -C-substituted-2-haloadenosine derivative App 20050215512 - Kohgo, Satoru ; et al. | 2005-09-29 |
| Fitness assay and associated methods App 20050158713 - Erickson, John W. ; et al. | 2005-07-21 |
| Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient App 20040106619 - Mitsuya, Hiroaki ; et al. | 2004-06-03 |
| 4'-C-ethynyl pyrimidine nucleosides and pharmaceutical compositions thereof Grant 6,403,568 - Ohrui , et al. June 11, 2 | 2002-06-11 |
| 4'-C-ethynyl pyrimidine nucleoside compounds App 20020022722 - Ohrui, Hiroshi ; et al. | 2002-02-21 |
| Method of inhibiting HIV replication with 2',3'-dideoxyadenosine Grant 5,616,566 - Mitsuya , et al. April 1, 1 | 1997-04-01 |
| 2',3'-dideoxy-2'-fluoro-purine nucleosides and methods for using same Grant 5,565,437 - Marquez , et al. October 15, 1 | 1996-10-15 |
| Lipophilic, aminohydrolase-activated prodrugs Grant 5,459,256 - Marquez , et al. October 17, 1 | 1995-10-17 |
| Treatment of retroviral induced dementia by administration of 2',3'-dideoxyinosine Grant 5,376,642 - Yarchoan , et al. December 27, 1 | 1994-12-27 |
| Method of treating HIV with 2',3'-dideoxyinosine Grant 5,254,539 - Mitsuya , et al. * October 19, 1 | 1993-10-19 |
| Anti-retroviral compounds Grant RE33,887 - Tam , et al. April 14, 1 | 1992-04-14 |
| Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds Grant 5,026,687 - Yarchoan , et al. June 25, 1 | 1991-06-25 |
| Antiviral compositions and methods Grant 4,879,277 - Mitsuya , et al. November 7, 1 | 1989-11-07 |
| Antiviral compositions and methods Grant 4,861,759 - Mitsuya , et al. August 29, 1 | 1989-08-29 |
| Anti-retroviral compounds Grant 4,837,311 - Tam , et al. June 6, 1 | 1989-06-06 |
| Immortalized T-lymphocyte cell line for testing HTLV-III inactivation Grant 4,704,357 - Mitsuya , et al. November 3, 1 | 1987-11-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 